Shuttle Pharmaceuticals Holdings (SHPH) Notes Payables (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Notes Payables came in at $23423.0 in Q1 2026, up 3.47% year-on-year from $22638.0 in Q1 2025, and down 76.5% quarter-over-quarter from $99687.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Notes Payables (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Notes Payables history runs 6 years deep, the most recent figure standing at $23423.0 for Q1 2026.
- On a quarterly basis, Notes Payables rose 3.47% year-over-year to $23423.0 in Q1 2026; TTM through Mar 2026 was $23423.0, a 3.47% increase from a year earlier, with the FY2025 full-year figure at $99687.0, down 47.61% from the prior year.
- Notes Payables eased to $23423.0 in Q1 2026 per SHPH's latest filing, from $99687.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.4 million in Q1 2023 and bottomed at $2035.0 in Q1 2024.
- The 5-year median for Notes Payables is $190270.0 (2024), against an average of $346176.3.
- Across the five-year window, Notes Payables sank 99.85% in 2024 and surged 1012.43% in 2025, its largest moves.
- Year by year, Notes Payables stood at $221000.0 in 2022, then soared by 169.68% to $595999.0 in 2023, then tumbled by 68.08% to $190270.0 in 2024, then sank by 47.61% to $99687.0 in 2025, then tumbled by 76.5% to $23423.0 in 2026.
- Per Business Quant, the three latest SHPH Notes Payables figures stand at $23423.0 (Q1 2026), $99687.0 (Q4 2025), and $8538.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,423.00 |
| Dec 31, 2025 | 99,687.00 |
| Sep 30, 2025 | 8,538.00 |
| Jun 30, 2025 | 65,326.00 |
| Mar 31, 2025 | 22,638.00 |
| Dec 31, 2024 | 190,270.00 |
| Sep 30, 2024 | 74,107.00 |
| Jun 30, 2024 | 826,235.00 |
| Mar 31, 2024 | 2,035.00 |
| Dec 31, 2023 | 595,999.00 |
| Sep 30, 2023 | 597,207.00 |
| Jun 30, 2023 | 390,706.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 221,000.00 |
| Sep 30, 2022 | 685,473.00 |
| Dec 31, 2021 | 94,025.00 |